johnson & johnson news

Johnson & Johnson, Intra

Hosted on MSN · 15h

Johnson & Johnson Acquires Intra-Cellular in $14.6 Billion Deal

Intra-Cellular Therapies makes Caplyta, a once-daily pill for adults with schizophrenia and bipolar-related depression

Business Insider · 17h

Hold Rating Reiterated for Intra-Cellular Therapies Amid Johnson & Johnson Acquisition at $132 per Share

In a report released today, Jeffrey Hung from Morgan Stanley downgraded Intra-Cellular Therapies (ITCI – Research Report) to a Hold, with a

Investopedia on MSN · 20h

Intra-Cellular Therapies Stock Pops as Johnson & Johnson Buys Firm for $14.6B

Key Takeaways Shares of Intra-Cellular Therapies jumped Monday morning after Johnson & Johnson announced plans to buy the biopharmaceutical company.Intra-Cellular shareholders will get $132 per share,

Jessica Simpson and Eric Johnson Split

CNN · 5h

Jessica Simpson and Eric Johnson announce separation after 10 years of marriage

Singer Jessica Simpson and Eric Johnson have announced their separation. Simpson said in a statement on Monday night that she and her husband of ten years have “been living separately” while “navigating a painful situation in our marriage.

Hindustan Times on MSN · 1h

Jessica Simpson confirms splitting from Eric Johnson after 10 years of marriage, says they are living separately

Jessica Simpson confirmed that she has been living separately from husband Eric Johnson and navigating a painful situation in her marriage.

Hosted on MSN · 1h

Jessica Simpson, 44, splits from husband of 10 years Eric Johnson as she issues 'painful' statement

Jessica Simpson and her husband Eric Johnson have announced their separation after 10 years of marriage. The singer and actress, 44, confirmed to People magazine that she and the former NFL player, 45,

Mike Johnson opposes California aid without 'conditions'

CNN on MSN · 12h

Mike Johnson suggests federal aid for California could come with conditions attached

House Speaker Mike Johnson (R-LA) tells CNN’s Manu Raju that he personally believes conditions should be placed on federal aid for California in wake of the wildfires.

USA TODAY on MSN · 8h

'Conditions' should be placed on California wildfire aid: House Speaker Mike Johnson

A number of Republicans are calling for conditions to any federal aid that goes to California as the state struggles with catastrophic wildfires.

Newsweek on MSN · 9h

Republicans Push Back On Mike Johnson's California Aid Remark

Some Republicans distanced themselves from Mike Johnson after he suggested conditioning disaster aid to California.

Deion Sanders, Ben Johnson among 7 options

U.S. News & World Report · 16h

Mike McCarthy Won't Return as the Cowboys' Coach. Deion Sanders Could Be a Candidate to Replace Him

Mike McCarthy will not return as coach of the Dallas Cowboys, who are going on three decades since their last Super Bowl title, owner Jerry Jones said Monday. Jones said the organization and McCarthy mutually agreed to part ways.

FOXSports on MSN · 14h

Cowboys coaching candidates: Deion Sanders, Ben Johnson among 7 options

Deion Sanders, Bill Belichick, Ben Johnson, and maybe even Jason Witten could emerge as candidates to replace Mike McCarthy in Dallas.

The New York Times · 14h

Cowboys coach candidates: Ben Johnson and other names Dallas should consider

Jerry Jones once famously said 500 coaches could have won Super Bowls with those early 1990s Dallas Cowboys teams. The owner and general manager has made six hires since winning two Super Bowls with Jimmy Johnson and one with Barry Switzer.

14hon MSN

Johnson & Johnson to Acquire Intra-Cellular in $15 Billion Deal

Johnson & Johnson agreed to acquire mental-illness drug developer Intra-Cellular Therapies for about $15 billion.

Cautious Optimism: Evaluating Johnson & Johnson’s Hold Rating Amid ITCI Acquisition Uncertainties

Wells Fargo analyst Larry Biegelsen has maintained their neutral stance on JNJ stock, giving a Hold rating yesterday.Stay Ahead of the ...

17hon MSN

Johnson & Johnson makes $15 billion bet on mental-health drugs

Pharma giant Johnson & Johnson is buying Intra-Cellular Therapies, eying sales growth above analysts’ expectations through ...

Johnson & Johnson Could Serve As High-Yield Bond Alternative

Johnson & Johnson remains a Buy for its stability and consistent dividends, despite short-term price fluctuations and modest ...

MassDevice5d

Johnson & Johnson MedTech halts Varipulse PFA cases due to stroke reports

Johnson & Johnson MedTech has temporarily paused all U.S. external evaluations and cases using its Varipulse pulse field ...

3don MSN

Johnson & Johnson stock outperforms competitors despite losses on the day

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Johnson & Johnson (JNJ) And Encourages Investors to Reach Out

NEW YORK, NY / ACCESSWIRE / January 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results